This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Guangzhou Reforgene Medicine Co., Ltd., Zhejiang Synsorbio Technology Co., Ltd., Guangzhou Reforgene Medicine Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Kaiwei Si in Gene Editing
Introduction
Kaiwei Si is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of gene editing, particularly through his innovative work at Zhejiang Synsorbio Technology Co., Ltd. His research focuses on developing novel technologies that enhance genetic manipulation.
Latest Patents
One of Kaiwei Si's notable patents is titled "Novel Cas Effector Proteins, Gene Editing Systems, and Uses Thereof." This patent represents a significant advancement in the tools available for gene editing, showcasing his expertise and innovative approach in this rapidly evolving field. He holds 1 patent that reflects his commitment to advancing scientific knowledge and practical applications.
Career Highlights
Throughout his career, Kaiwei Si has demonstrated a strong dedication to research and development. His work at Zhejiang Synsorbio Technology Co., Ltd. has positioned him as a key player in the biotechnology sector. His innovative contributions have the potential to impact various applications in medicine and agriculture.
Collaborations
Kaiwei Si has collaborated with notable colleagues, including Liancheng Huang and Hui Xu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.
Conclusion
In summary, Kaiwei Si is an influential inventor whose work in gene editing is paving the way for future innovations. His patent and collaborations highlight his commitment to advancing biotechnology and improving genetic manipulation techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile